Polfa Poznan SA
Division of GlaxoSmithKline PLC
Latest From Polfa Poznan SA
As the European Union gears itself up to welcome ten new countries in 2004, the pharmaceutical industry fears that parallel trade--already worth over 1 billion Euros ($.9 billion) a year--could increase. Some drug companies are trying to restrict supply to wholesalers, but legislation is likely to soon catch up.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.